Insmed Incorporated

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. 

CEO
William H. Lewis
CEOWilliam H. Lewis
Employees
1,664
Employees1,664
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
1988
Founded1988
Employees
1,664
Employees1,664

INSM Key Statistics

Market cap
24.59B
Market cap24.59B
Price-Earnings ratio
-39.98
Price-Earnings ratio-39.98
Dividend yield
—
Dividend yield—
Average volume
4.26M
Average volume4.26M
High today
$116.37
High today$116.37
Low today
$110.01
Low today$110.01
Open price
$113.60
Open price$113.60
Volume
5.18M
Volume5.18M
52 Week high
$212.75
52 Week high$212.75
52 Week low
$90.39
52 Week low$90.39

Stock Snapshot

With a market cap of 24.59B, Insmed Incorporated(INSM) trades at $112.01. The stock has a price-to-earnings ratio of -39.98.

On 2026-10-30, Insmed Incorporated(INSM) stock moved within a range of $110.01 to $116.37. With shares now at $112.01, the stock is trading +1.8% above its intraday low and -3.7% below the session's peak.

Trading activity shows a volume of 5.18M, compared to an average daily volume of 4.26M.

Over the past 52 weeks, Insmed Incorporated(INSM) stock has traded between a high of $212.75 and a low of $90.39.

Over the past 52 weeks, Insmed Incorporated(INSM) stock has traded between a high of $212.75 and a low of $90.39.

INSM News

Investing.com 16h
Goldman Sachs reiterates Insmed stock rating on Brinsupri beat - Investing.com

...

Goldman Sachs reiterates Insmed stock rating on Brinsupri beat - Investing.com
Simply Wall St 23h
Insmed Stock Jumps After Q3 Earnings Fuel Growth And Loss Debate

Insmed stock ripped higher on Friday, jumping about 15% to US$111.59 after its third quarter 2026 report, as traders rushed to reprice the story. The move came...

Analyst ratings

96%

of 25 ratings
Buy
96%
Hold
4%
Sell
0%

People also own

Based on the portfolios of people who own INSM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.